MARKET

ALPN

ALPN

Alpine Immune Sc
NASDAQ
11.75
-0.40
-3.29%
After Hours: 11.52 -0.23 -1.96% 17:40 09/20 EDT
OPEN
12.16
PREV CLOSE
12.15
HIGH
12.18
LOW
11.41
VOLUME
191.90K
TURNOVER
0
52 WEEK HIGH
14.92
52 WEEK LOW
4.820
MARKET CAP
578.12M
P/E (TTM)
-8.0701
1D
5D
1M
3M
1Y
5Y
Is it a Good Idea to Invest in KalVista (KALV) Stock Now?
NASDAQ · 22h ago
Zacks Industry Outlook Highlights Corcept Therapeutics, Aurinia Pharmaceuticals, Alpine Immune Sciences, KalVista Pharmaceuticals and Cardiol Therapeutics
NASDAQ · 1d ago
5 Stocks to Buy as Drug Industry Displays Strong Fundamentals
NASDAQ · 2d ago
Weekly Report: what happened at ALPN last week (0911-0915)?
Weekly Report · 2d ago
HC Wainwright & Co. Reiterates Alpine Immune Sciences (ALPN) Buy Recommendation
NASDAQ · 09/13 12:34
HC Wainwright & Co. Reiterates Buy on Alpine Immune Sciences, Maintains $17 Price Target
Benzinga · 09/13 10:27
H.C. Wainwright Keeps Their Buy Rating on Alpine Immune Sciences (ALPN)
TipRanks · 09/13 10:25
Alpine Immune Sciences Presents First Preclinical Data for Povetacicept in Myasthenia Gravis at the American Neurological Association Annual Meeting
Benzinga · 09/12 12:51
More
About ALPN
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. The Company's scientific platform uses a directed evolution process to convert native immune system proteins from the immunoglobulin super family (IgSF) into multi-targeted therapeutics capable of modulating the human immune system. The Company’s product candidates include ALPN-101, ALPN-202 and ALPN-303. ALPN-101 is a dual inducible T cell costimulator (ICOS) and cluster of differentiation 28 (CD28) antagonist intended for the treatment of autoimmune and inflammatory diseases. Its oncology program is ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor intended for the treatment of cancer. ALPN-303 is a dual B-cell cytokine antagonist for the treatment of B-cell mediated diseases.

Webull offers kinds of Alpine Immune Sciences Inc stock information, including NASDAQ:ALPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALPN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ALPN stock methods without spending real money on the virtual paper trading platform.